According to Fortune Business Insights, the global Opioids Market size was valued at USD 26.08 billion in 2025. The market is projected to grow from USD 27.39 billion in 2026 to USD 40.46 billion by 2034, exhibiting a CAGR of 5.00% during the forecast period of 2026–2034. Increasing demand for effective pain management, rising prevalence of chronic diseases, growing surgical procedures, and advancements in pharmaceutical formulations are contributing to market expansion. The development of innovative opioid medications and increasing research activities are also supporting industry growth.
Market Overview
The global opioids market is experiencing steady growth due to increasing healthcare requirements and the prevalence of chronic pain conditions.
Opioid medications remain essential in selected clinical situations where alternative treatments do not provide adequate pain relief. Their applications extend beyond pain management to cough suppression and certain gastrointestinal conditions.
According to data referenced in the report, approximately 51.6 million adults in the United States experienced chronic pain in 2021, while 17.1 million experienced high-impact chronic pain.
This substantial disease burden highlights the continuing importance of effective pain management solutions.
Pharmaceutical manufacturers are focusing on developing improved formulations, enhancing medication delivery, and addressing treatment-related safety concerns.
For detailed market insights: https://www.fortunebusinessinsights.com/opioids-market-109339
Market Trends
Increasing Development of Advanced Opioid Formulations
Pharmaceutical companies are investing in research and development to introduce innovative opioid formulations with improved delivery mechanisms.
Extended-release injections, prefilled syringes, and other advanced formulations are gaining attention for their potential to improve treatment administration and medication management.
Growing Focus on Opioid Use Disorder Treatment
The development of medications for opioid use disorder represents an important pharmaceutical trend.
In May 2023, Braeburn received U.S. FDA approval for BRIXADI, an extended-release buprenorphine injection used to treat opioid use disorder.
This development highlights the industry's increasing attention to addiction treatment alongside conventional pain management.
Advancements in Medication Administration
Manufacturers are introducing pharmaceutical delivery systems designed to improve dosing accuracy and reduce medication wastage.
Prefilled injection products are particularly relevant in hospitals and other controlled healthcare environments.
Market Drivers
Rising Prevalence of Chronic Pain
The increasing prevalence of chronic illnesses is a major factor supporting demand for opioid medications.
Patients experiencing cancer-related pain, neuropathic pain, and severe musculoskeletal conditions may require opioid-based treatment when clinically appropriate.
Increasing Number of Surgical Procedures
The growing volume of surgical procedures contributes to demand for postoperative pain management.
Short-acting opioids are particularly important for providing rapid relief in selected acute pain situations.
Growing Geriatric Population
An aging population contributes to increasing rates of chronic diseases and associated pain conditions.
This demographic trend supports continued demand for effective pharmaceutical pain management solutions.
Pharmaceutical Research and Development
Ongoing investments in drug development are encouraging the introduction of improved opioid formulations.
Regulatory approvals, product launches, and pharmaceutical partnerships are also influencing market development.
Market Segmentation
The opioids market is segmented by drug class, route of administration, application, distribution channel, and geography.
By Drug Class
The market includes:
Short-Acting Opioids: These medications provide relatively rapid pain relief and are commonly used for acute and breakthrough pain.
Long-Acting Opioids: These formulations provide extended medication release and may be used in carefully selected patients requiring sustained pain management.
The short-acting opioids segment held the dominant market share in 2023, supported by immediate pain relief, flexible dosing, and widespread postoperative applications.
By Route of Administration
The market is categorized into oral, parenteral, transdermal, and other administration routes.
Oral medications include tablets and capsules, while parenteral products are administered through injections. Transdermal formulations deliver medication through the skin.
By Application
Major applications include:
Pain Management
Cancer Pain
Neuropathic Pain
Osteoarthritis Pain
Other Pain Conditions
Cough Suppression
Other Applications
Pain management represents a central application area due to the clinical importance of controlling moderate to severe pain.
By Distribution Channel
The market includes hospital pharmacies, retail pharmacies and drug stores, and online pharmacies.
Hospital pharmacies support inpatient treatment and postoperative care, while retail pharmacies provide access to prescribed medications for outpatient treatment.
Key Players in the Opioids Market
Major companies operating in the global opioids market include:
Purdue Pharma L.P. – A pharmaceutical company associated with prescription pain medications.
Mallinckrodt – Develops and supplies pharmaceutical products, including pain management medications.
Grünenthal – Focuses on pharmaceutical treatments, particularly pain-related therapies.
Amneal Pharmaceuticals LLC – Provides generic and specialty pharmaceutical products.
Fresenius Kabi AG – Supplies injectable medicines and pharmaceutical products for healthcare facilities.
Pfizer Inc. – A global pharmaceutical company with a broad medication portfolio.
Boehringer Ingelheim International GmbH – A research-driven pharmaceutical organization.
Janssen Pharmaceuticals – A pharmaceutical business associated with Johnson & Johnson.
These companies are identified in the report as important participants in the competitive landscape.
Regional Analysis
North America
North America held the dominant share of the global opioids market in 2023 and is expected to maintain its leading position during the forecast period.
The region benefits from developed healthcare infrastructure, established pharmaceutical distribution systems, and significant demand for pain management medications.
The increasing prevalence of chronic diseases and aging populations also influences regional demand.
Europe
Europe represents an important regional market, covering countries such as Germany, the United Kingdom, France, Italy, and Spain.
Healthcare requirements related to chronic pain and access to pharmaceutical treatments contribute to the region's market activity.
Asia Pacific
Asia Pacific includes major markets such as Japan, China, India, and Australia.
Expanding healthcare requirements, surgical treatment needs, and pharmaceutical development create opportunities for opioid medication manufacturers.
Latin America
Brazil and Mexico are among the countries included in the Latin American market assessment.
Demand for effective pain management and the availability of prescription medications influence regional development.
Middle East & Africa
The Middle East & Africa market includes GCC countries, South Africa, and other regional economies.
Healthcare infrastructure development and access to pharmaceutical treatments remain important considerations for future growth.
Competitive Landscape
The global opioids market includes established pharmaceutical manufacturers competing through product development, formulation improvements, and strategic collaborations.
Companies are focusing on research activities and pharmaceutical innovations to improve medication administration and expand treatment options.
In July 2023, Fresenius Kabi introduced Simplist prefilled syringes containing Fentanyl Citrate Injection, USP. The product was developed to support accurate medication administration and reduce drug wastage.
In November 2022, Grünenthal partnered with Kyowa Kirin to establish a pharmaceutical portfolio covering multiple therapeutic areas, including pain management.
Such developments demonstrate the importance of product innovation and business partnerships within the industry.
Future Outlook
The global opioids market is expected to experience steady growth through 2034, supported by continuing demand for clinically appropriate pain management treatments.
The increasing prevalence of chronic diseases, aging populations, and ongoing surgical procedures will remain important factors influencing pharmaceutical demand.
Future developments are expected to emphasize improved medication formulations, controlled delivery systems, and treatment approaches that address opioid-related risks.
The expansion of research into opioid use disorder therapies may also contribute to pharmaceutical innovation.
However, concerns regarding dependence, addiction, respiratory depression, and other adverse effects will continue to influence prescribing decisions, regulatory oversight, and product development.
Manufacturers that prioritize medication safety, clinical effectiveness, and innovation will be better positioned to respond to changing healthcare requirements.
Get a free sample PDF: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/opioids-market-109339
Conclusion
The global opioids market is projected to expand from USD 27.39 billion in 2026 to USD 40.46 billion by 2034, registering a CAGR of 5.00%.
Rising chronic pain prevalence, increasing surgical procedures, and advancements in pharmaceutical formulations are important factors supporting market growth.
North America remains the leading regional market, while short-acting opioids represent the dominant drug-class segment identified in the report.
Despite concerns surrounding addiction and adverse effects, opioids continue to have an important role in selected medical treatments. Continued innovation, responsible prescribing, and improved medication delivery are expected to influence the industry's future.
Frequently Asked Questions (FAQs)
1. How Big Is the Opioids Market?
Fortune Business Insights states that the global opioids market was valued at USD 26.08 billion in 2025 and is projected to reach USD 40.46 billion by 2034.
2. At What CAGR Is the Opioids Market Expected to Grow During 2026–2034?
The global opioids market is projected to register a CAGR of 5.00% during the forecast period of 2026–2034.
3. Which Segment Dominates the Opioids Market?
The short-acting opioids segment held the dominant share in 2023, supported by rapid pain relief, flexible dosing, and applications in postoperative and breakthrough pain management.
4. Who Are the Major Players in the Opioids Market?
Major players include Purdue Pharma L.P., Mallinckrodt, Grünenthal, Amneal Pharmaceuticals LLC, Fresenius Kabi AG, and Pfizer Inc.
5. What Are the Key Trends Driving the Opioids Market?
Major trends include:
Development of advanced opioid formulations and medication delivery systems.
Increasing research into treatments for opioid use disorder.
New pharmaceutical product launches, regulatory approvals, and strategic partnerships.
What’s Driving Japan’s Market? Discover the Latest Opioids Market Insights